Filing search / Ownership / Virpax Pharmaceuticals, Inc. / Page 3

8-K

fb9oijh74b 0l

26 Mar 24

Virpax Pharmaceuticals Reports 2023 Year-End Results

7:30am

8-K

j68tuz01 xwlj3e

18 Mar 24

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

6:30am

8-K

d0awpla zhg4mem15x

1 Mar 24

Virpax Pharmaceuticals Announces Reverse Stock

4:05pm

8-K

2z8crux1ju

29 Dec 23

Submission of Matters to a Vote of Security Holders

7:30am

8-K

fwg0wibf78l76l6

13 Dec 23

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

8:30am

8-K

3tx 18ffq

7 Dec 23

Departure of Directors or Certain Officers

8:58am

PRE 14A

dks a4tof

21 Nov 23

Preliminary proxy

4:57pm

8-K

gfoq06d0gh3so9tl4

17 Nov 23

Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing

7:30am

8-K

std0z4ozp

17 Nov 23

Virpax Pharmaceuticals Announces Leadership Transition

7:15am

8-K

94o6me

16 Nov 23

Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments

4:51pm

NT 10-Q

pth9afndjc eo67no3

15 Nov 23

Notice of late quarterly filing

3:03pm

8-K

icujrb3n86u3 8c4u

11 Oct 23

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

4:10pm

8-K

6hw6aprzij

5 Sep 23

Virpax Pharmaceuticals Updates on Litigation

9:28am

8-K

60m8ib1h

16 Aug 23

Departure of Directors or Certain Officers

5:00pm

8-K

a5aiq9 ywqk3

14 Aug 23

Virpax Pharmaceuticals Reports 2023 Second Quarter Results and Recent Developments

9:05am

8-K

k9gv4zwg98b8xi

26 Jul 23

Submission of Matters to a Vote of Security Holders

4:10pm

DEFA14A

e16u6h

22 Jun 23

Additional proxy soliciting materials

8:14am